Publisher
Springer International Publishing
Reference61 articles.
1. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29:630–4.
2. Rajamannan NM, Sangiorgi G, Springett M, et al. Experimental hypercholesterolemia induces apoptosis in the aortic valve. J Heart Valve Dis. 2001;10:371–4.
3. Rajamannan NM, Spelsberg TC, Moura LM. Mitral valve disease in a patient with familial hypercholesterolemia. Rev Port Cardiol. 2010;29:841–2.
4. Pedersen TR. Secondary prevention of coronary heart disease with lipid lowering drugs. Evaluating outcome eliminates the controversy. Der Internist (Berl). 1995;36:1174–8.
5. Kolodziejczak M, Navarese EP. Role of PCSK9 antibodies in cardiovascular disease: critical considerations of mortality and neurocognitive findings from the current literature. Atherosclerosis. 2016;247:189–92.